A CKD patient develops serum K+ 7.2 mEq/L without ECG changes. Best initial management?
The body fluid compartments of a patient were measured, showing the following ion concentrations: - Sodium (Na): $10 \mathrm{mEq} / \mathrm{L}$ - Potassium (K): $140 \mathrm{mEq} / \mathrm{L}$ - Chloride (Cl): $15 \mathrm{mEq} / \mathrm{L}$ Based on these values, which fluid compartment is being described?
Which of the following is the primary mechanism that drives sodium reabsorption in the proximal tubule?
A patient has hyperaldosteronism. Which lab finding is expected?
All are examples of negative feedback except
Result of liquorice ingestion
Tetany in muscle occurs in spite of normal serum Ca2+ level. Which ion is responsible?
In Bartter's syndrome there is a defect in
On insulin administration, what change is expected in the extracellular fluid (ECF)?
In renal failure, what is the primary cause of metabolic acidosis?
Explanation: **Calcium gluconate** - **Calcium gluconate** is the best initial management for severe hyperkalemia, particularly when the potassium level is very high (above 6.5 mEq/L) even without ECG changes [1]. It acts quickly to directly stabilize the cardiac membrane by **antagonizing the effects of potassium on myocardial excitability**, thereby preventing life-threatening arrhythmias [1]. - It provides immediate cardioprotection, buying time for other therapies to shift potassium into cells or remove it from the body. *Emergency dialysis* - While **dialysis** is the most effective way to remove potassium from the body, it is typically reserved for cases of severe, refractory hyperkalemia, or when other therapies have failed [3]. - It is not the *initial* management for immediate cardiac stabilization, especially if no ECG changes are present and calcium can be administered more rapidly. *Sodium polystyrene* - **Sodium polystyrene sulfonate (Kayexalate)** is a potassium-binding resin that works in the gastrointestinal tract to exchange sodium for potassium, thus removing potassium from the body. - Its onset of action is slow (hours to days), making it inappropriate for acute, severe hyperkalemia requiring immediate intervention. *Insulin with glucose* - **Insulin with glucose** therapy promotes the intracellular shift of potassium, temporarily lowering serum potassium levels [2]. - While effective, its onset of action is typically 15-30 minutes, and it functions as a temporary measure to redistribute potassium, not to acutely stabilize the cardiac membrane, which is the primary concern when potassium is severely elevated.
Explanation: ***ICF*** - The measured ion concentrations, especially **high potassium (140 mEq/L)** and **low sodium (10 mEq/L)**, are characteristic of the **intracellular fluid (ICF)**, where potassium is the primary cation and sodium is kept low by the Na+/K+-ATPase pump. - **Chloride levels (15 mEq/L)** are also significantly lower in the ICF compared to extracellular fluids. *Plasma* - Plasma typically has **high sodium (around 140 mEq/L)** and **low potassium (around 4 mEq/L)**, which contradicts the given measurements. - Chloride levels in plasma are usually much higher, around **100-105 mEq/L**. *Interstitial fluid* - Interstitial fluid has an electrolyte composition very similar to plasma, with **high sodium** and **low potassium**, differing mainly in protein content. - This composition is not consistent with the given measurements. *ECF* - The ECF (extracellular fluid), which includes both plasma and interstitial fluid, is characterized by **high sodium** and **low potassium**. - The given ion concentrations, particularly the very **high potassium** and **low sodium**, are directly opposite to the typical ECF profile.
Explanation: ***Active sodium transport via the Na+-K+-ATPase pump at the basolateral membrane.*** - This pump **actively transports sodium out of the cell** into the interstitial fluid, creating a low intracellular sodium concentration. - The **Na+-K+-ATPase** is the primary driver of sodium reabsorption throughout the nephron, creating the electrochemical gradient for other sodium transporters. *Sodium reabsorption through cotransport with amino acids at the luminal membrane.* - While **sodium-amino acid cotransport** does occur in the proximal tubule, it accounts for only a fraction of total sodium reabsorption. - The primary driving force for this cotransport is the **low intracellular sodium concentration** maintained by the Na+-K+-ATPase. *Sodium reabsorption through cotransport with glucose at the luminal membrane.* - **Sodium-glucose cotransporters (SGLTs)** are crucial for glucose reabsorption in the proximal tubule, moving glucose into the cell along with sodium. - However, glucose cotransport represents a specific mechanism for glucose handling, not the overarching mechanism for sodium reabsorption. *Sodium reabsorption through countertransport with hydrogen ions at the luminal membrane.* - The **Na+-H+ exchanger (NHE3)** is significant for exchanging sodium for hydrogen ions at the luminal membrane in the proximal tubule. - This mechanism is important for **acid-base balance** and some sodium reabsorption, but it is secondary to the Na+-K+-ATPase in driving the overall sodium gradient.
Explanation: ***Hypokalemia*** - **Aldosterone** increases the excretion of **potassium** in the kidneys, leading to decreased serum potassium levels [1]. - This effect is mediated by aldosterone's action on the principal cells of the collecting duct, promoting potassium secretion into the urine [1]. *Metabolic acidosis* - **Hyperaldosteronism** typically causes **metabolic alkalosis** due to increased hydrogen ion excretion by the kidneys [1]. - Aldosterone promotes the reabsorption of sodium and water, and the excretion of potassium and hydrogen ions, leading to alkalosis [2]. *Hyperkalemia* - **Aldosterone's primary role** is to promote **potassium excretion** in the kidneys [1]. - Therefore, **excessive aldosterone** production would lead to **hypokalemia**, not hyperkalemia. *Hyponatremia* - **Aldosterone** promotes **sodium reabsorption** in the kidneys, which usually leads to normal or even slightly elevated serum sodium levels [1]. - **Hyponatremia** would be an unexpected finding in hyperaldosteronism [3].
Explanation: ***Coagulation of the blood*** - **Blood coagulation** is a classic example of **positive feedback**, where the initial clotting process amplifies itself until bleeding stops - Platelets aggregate and release factors that promote further platelet aggregation and activation of the clotting cascade, thereby **accelerating the response** rather than diminishing it - This is the exception among the options, as it represents positive feedback while all others are negative feedback *Regulation of blood CO2 level* - The regulation of **blood CO2 levels** is a vital example of **negative feedback**, where an increase in CO2 stimulates breathing to expel excess CO2 - This mechanism works to return the blood CO2 concentration to its homeostatic set point, thus **counteracting the initial stimulus** - Central and peripheral chemoreceptors detect elevated CO2 and trigger increased ventilation *Regulation of pituitary hormones* - The regulation of **pituitary hormones** involves **negative feedback loops**, where high levels of target gland hormones inhibit the release of stimulating hormones from the pituitary and hypothalamus - For example, high thyroid hormone levels inhibit TSH release from the pituitary and TRH from the hypothalamus - This effectively **reduces the initial stimulus** and maintains hormonal balance *Regulation of blood pressure* - The regulation of **blood pressure** is primarily controlled by **negative feedback mechanisms** involving baroreceptors, which detect changes in pressure - If blood pressure rises, baroreceptors in the carotid sinus and aortic arch signal the medulla to reduce heart rate and dilate blood vessels - This response **lowers the pressure back to the set point**, maintaining cardiovascular homeostasis
Explanation: ***Hypokalemic alkalosis*** - **Licorice** contains **glycyrrhizic acid**, which inhibits **11β-hydroxysteroid dehydrogenase** in the kidneys, preventing the conversion of cortisol to inactive cortisone. - This leads to increased cortisol acting on **mineralocorticoid receptors**, mimicking **aldosterone excess**, resulting in **sodium reabsorption**, **potassium excretion** (hypokalemia), and **hydrogen ion excretion** (metabolic alkalosis). *Hyperkalemic alkalosis* - This option is incorrect because licorice ingestion leads to **hypokalemia** due to increased potassium excretion, not hyperkalemia. - While it does cause alkalosis, the associated potassium imbalance is the opposite of this choice. *Hypokalemic acidosis* - This option is incorrect because licorice ingestion causes a **metabolic alkalosis** due to increased hydrogen ion excretion, not acidosis. - Although it correctly identifies hypokalemia, the acid-base disturbance is wrong. *Hypernatremic acidosis* - This option is incorrect as licorice ingestion initially causes **sodium and water retention** (which can lead to hypernatremia in severe cases, but is not the primary driver of the acid-base), but primarily leads to **metabolic alkalosis**, not acidosis. - The combination of hypernatremia and acidosis is not characteristic of licorice toxicity.
Explanation: ***Ionized Ca2+*** - While total serum calcium might be normal, **tetany** is specifically caused by a decrease in the concentration of **ionized (free) calcium** in the extracellular fluid. - Ionized calcium is the physiologically active form of calcium responsible for neuromuscular excitability. *Mg2+* - **Hypomagnesemia** can exacerbate hypocalcemia and contribute to tetany, but it is not the primary ion directly responsible for tetany when **total serum calcium is normal**. - A deficiency in Mg2+ can impair the release of **parathyroid hormone** and reduce target organ responsiveness to PTH. *K+* - Abnormalities in **potassium levels** (hypokalemia or hyperkalemia) primarily affect cardiac and muscular excitability, leading to arrhythmias or muscle weakness/paralysis. - While electrolyte imbalances are interconnected, changes in potassium are not the direct cause of tetany due to calcium's role. *Na+* - **Sodium ions** are crucial for nerve impulse transmission and muscle contraction by establishing the resting membrane potential and initiating action potentials. - However, direct changes in sodium concentration do not typically cause tetany; rather, they can lead to neurological symptoms like seizures (hyponatremia) or altered mental status (hypernatremia).
Explanation: ***Thick ascending limb of LOH*** - **Bartter's syndrome** is characterized by a genetic defect affecting the **Na-K-2Cl cotransporter (NKCC2)** located in the thick ascending limb of the loop of Henle. - This defect impairs the reabsorption of sodium, potassium, and chloride ions, leading to significant **electrolyte imbalances** such as hypokalemia, metabolic alkalosis, and hyperreninemia. *Descending limb of LOH* - The descending limb is primarily permeable to **water** due to aquaporin channels, and impermeable to solutes. - Defects in this segment are not typically associated with the electrolyte derangements seen in Bartter's syndrome. *DCT* - The **distal convoluted tubule (DCT)** is where fine-tuning of sodium and calcium reabsorption occurs, primarily through the Na-Cl cotransporter (NCC) and active calcium transport. - Defects in the DCT are characteristic of **Gitelman's syndrome**, which has similar but generally milder symptoms compared to Bartter's syndrome. *PCT* - The **proximal convoluted tubule (PCT)** is responsible for the bulk reabsorption of filtered substances, including glucose, amino acids, bicarbonate, and about 65-70% of filtered sodium. - While defects here can lead to various syndromes (e.g., Fanconi syndrome), they do not directly cause the specific electrolyte abnormalities seen in Bartter's syndrome.
Explanation: **Hypoglycemia (Correct Answer)** - Insulin promotes the uptake of **glucose** from the ECF into cells, primarily muscle and adipose tissue - This action leads to a decrease in ECF **glucose concentration**, resulting in **hypoglycemia** if insulin levels are excessive or glucose intake is insufficient - This is the primary and most significant change in ECF composition after insulin administration *Hyperkalemia (Incorrect)* - Insulin actually stimulates the cellular uptake of **potassium**, moving it from the ECF into the intracellular fluid - Therefore, insulin administration typically causes **hypokalemia**, not hyperkalemia - This effect is sometimes used therapeutically to treat hyperkalemia by driving potassium into cells *Hyponatremia (Incorrect)* - Insulin primarily affects **glucose** and **potassium** metabolism and does not directly cause changes in sodium concentration in the ECF - **Hyponatremia** would be more associated with altered water balance or disorders of kidney function, not direct insulin effects - Sodium homeostasis is regulated by the renin-angiotensin-aldosterone system and ADH *Hypocalcemia (Incorrect)* - Insulin has no direct effect on **calcium** levels or its regulation in the ECF - **Calcium homeostasis** is primarily regulated by parathyroid hormone (PTH), vitamin D, and calcitonin, independent of insulin action - Changes in calcium concentration are not expected with insulin administration
Explanation: ***Decreased excretion of acids*** - In **renal failure**, the kidneys lose their ability to effectively excrete metabolic acid byproducts, leading to their accumulation in the body. - This accumulation of acids, such as **sulfates**, **phosphates**, and **urea**, consumes bicarbonate buffers, resulting in metabolic acidosis. *Increased H+ production* - While overproduction of **H+ ions** can cause acidosis, like in **ketoacidosis** or **lactic acidosis**, it's not the primary underlying mechanism in most cases of renal failure. - The problem in renal failure is primarily one of **impaired elimination**, not excessive generation, of acids. *Loss of HCO3-* - Loss of **bicarbonate (HCO3-)** can occur in conditions like severe diarrhea or renal tubular acidosis, but it's not the primary cause of metabolic acidosis in general renal failure. - In renal failure, decreased **ammoniagenesis** and impaired reabsorption of bicarbonate can contribute, but the main driver is reduced acid excretion. *Use of diuretics* - The use of **diuretics** (especially loop or thiazide diuretics) typically causes **metabolic alkalosis** due to increased potassium and hydrogen ion excretion, rather than acidosis. - Some diuretics, like **carbonic anhydrase inhibitors**, can cause a mild metabolic acidosis, but this is less common and not the primary cause of renal failure-associated acidosis.
Get full access to all questions, explanations, and performance tracking.
Start For Free